Inclusion of Under-Represented Groups Core
Inclusion of Under-Represented Groups Core
批准号:
10601065
负责人:
CAREY E GLEASON
金额:
$29.57万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-03-31
关键词:
AddressAdultAffectAfrican AmericanAfrican American populationAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanAmyloidAutopsyBiologicalBiological MarkersBrainCardiovascular DiseasesCensusesCerebrospinal FluidClinicalClinical TrialsCollaborationsCollectionCommunitiesConsultationsDataDementiaDiabetes MellitusDietDiseaseEducationEnsureEnvironmentFundingFutureGoalsHealthcareHigh PrevalenceIncidenceIndividualInstitutionInsulin ResistanceLabelLeftLinkMemoryMinority RecruitmentModelingNative AmericansNot Hispanic or LatinoObesityOneidaParticipantPopulationPopulation HeterogeneityPositron-Emission TomographyPrevalencePrevention strategyProtocols documentationPublicationsRaceResearchResearch PersonnelRiskRoleScienceUnderrepresented PopulationsVariantWeightWisconsinWorkcardiovascular risk factorclinical centercognitive changecohortcommunity engagementdata managementdemographicsearly onsetexperiencehealth disparityhealthy agingmiddle agemild cognitive impairmentneuralneuroimagingnoveloutreachparticipant retentionpre-clinicalpreclinical studypreventprogramsracial populationracismrecruitsuccesstau Proteinstheoriestreatment strategyvascular risk factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - INCLUSION OF UNDERREPRESENTED GROUPS CORE (CORE F)
The Inclusion of Underrepresented Groups (URG) Core currently works with the Clinical; Outreach, Recruitment,
and Engagement (ORE); Data Management and Statistical; and Biomarker Cores to identify and resolve the
barriers to research participation for African and Native Americans. In this third round of Wisconsin Alzheimer's
Disease Research Center (ADRC) funding, the URG Core will continue to be fully integrated with the Center,
assisting investigators to engage Native and African American communities, ensuring adequate inclusion to
answer scientific questions and optimize generalizability of findings. The URG Core's effort will include
recruitment of middle-aged URG participants. Ages 45 to 65, this cohort is known as our IMPACT participants
(Investigating Memory in Preclinical AD-Causes and Treatment). The URG Core will also emphasize retention
of existing URG participants and replenishment of URG participants who have left the Clinical Core. Toward this,
we will accomplish the following Specific Aims:
Aim 1: Working with the ORE and Clinical Cores, the URG Core will promote recruitment, retention, and
replenishment of participants from URG into the Clinical Core so that URG membership continues to
represent more than 20% of the overall Clinical Core membership.
Sub-Aim 1a: Through collaborations with the African American community, the URG core will promote
recruitment, retention and replenishment of African American participants into the Clinical Core.
Sub-Aim 1b: Through collaborations with the Native American community, the URG core will promote
recruitment, retention and replenishment of Native American participants into the Clinical Core.
Aim 2: In concert with the Biomarkers Core, the URG Core will promote recruitment and retention of participants
from URG into biomarkers studies, including the collection of cerebrospinal fluid, amyloid and tau PET
imaging, and other novel neuroimaging and biomarker studies.
Aim 3: URG Core will provide consultation and support for approved Center-affiliated studies seeking to recruit
and retain research participants from URGs into research protocols, clinical trials. and autopsy.
Recent publications suggest that African and Native Americans demonstrate the highest prevalence and
incidence of both early-onset and late-onset cases of AD and related dementias. As a result, it is imperative to
develop AD treatment and prevention strategies effective for a heterogeneous US population, especially those
segments most affected by AD and related disorders. The URG Core's role is to ensure adequate inclusion of
URG into the Clinical Core and Wisconsin ADRC-affiliated studies so that AD-related health disparities are fully
addressed. Our past and future successes are founded on a model of programmatic community engagement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project
-
批准号:10623223
-
项目类别:
-
资助金额:$204.25万
-
财政年份:2022
-
负责人:CAREY E GLEASON
-
依托单位:
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project
-
批准号:10447514
-
项目类别:
-
资助金额:$180.07万
-
财政年份:2022
-
负责人:CAREY E GLEASON
-
依托单位:
Inclusion of Under-Represented Groups Core
-
批准号:10385836
-
项目类别:
-
资助金额:$54.65万
-
财政年份:2019
-
负责人:CAREY E GLEASON
-
依托单位:
Admin Supplement - Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy
-
批准号:10163429
-
项目类别:
-
资助金额:$41.56万
-
财政年份:2017
-
负责人:CAREY E GLEASON
-
依托单位:
Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy
-
批准号:9422848
-
项目类别:
-
资助金额:$1063.89万
-
财政年份:2017
-
负责人:CAREY E GLEASON
-
依托单位:
African AMERICANS Fighting Alzheimer's In Midlife
-
批准号:10198394
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2016
-
负责人:CAREY E GLEASON
-
依托单位:
African Americans Fighting Alzheimer’s in Midlife (AA-FAIM)
-
批准号:10589654
-
项目类别:
-
资助金额:$274.46万
-
财政年份:2016
-
负责人:CAREY E GLEASON
-
依托单位:
African AMERICANS Fighting Alzheimer's In Midlife
-
批准号:9476898
-
项目类别:
-
资助金额:$75.76万
-
财政年份:2016
-
负责人:CAREY E GLEASON
-
依托单位:
African AMERICANS Fighting Alzheimer's In Midlife
-
批准号:9913432
-
项目类别:
-
资助金额:$75.39万
-
财政年份:2016
-
负责人:CAREY E GLEASON
-
依托单位:
Alzheimer's Disease: Potential Benefit of Isoflavones
-
批准号:7472379
-
项目类别:
-
资助金额:$13.85万
-
财政年份:2004
-
负责人:CAREY E GLEASON
-
依托单位:
Alzheimer's Disease: Potential Benefit of Isoflavones
-
批准号:7115754
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2004
-
负责人:CAREY E GLEASON
-
依托单位:
Alzheimer's Disease: Potential Benefit of Isoflavones
-
批准号:6815465
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2004
-
负责人:CAREY E GLEASON
-
依托单位:
Alzheimer's Disease: Potential Benefit of Isoflavones
-
批准号:7261341
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2004
-
负责人:CAREY E GLEASON
-
依托单位:
Alzheimer's Disease: Potential Benefit of Isoflavones
-
批准号:6935812
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2004
-
负责人:CAREY E GLEASON
-
依托单位:
Inclusion of Under-Represented Groups Core
-
批准号:9922856
-
项目类别:
-
资助金额:$34.45万
-
财政年份:--
-
负责人:CAREY E GLEASON
-
依托单位:
海外基金